Market Research | China Artificial Joint Market Research Report (2023)
This report is updated on an annual basis.
01
Product Introduction
1. Product classification
According to Medical Device Classification Catalogue 2017 of NMPA, artificial joints belong to the 13th category of passive implant devices, and the management category is Ⅲ. Since artificial joints in China are mainly knee and hip joints, this paper only calculates the above two secondary categories.
|
Medical Device Classification Catalogue 2017 |
||
|
Broad Heading |
Class I |
Class II |
| Passive implant devices | Joint replacement implants | 01 hip prosthesis, 02 hip prosthesis |
On the track, artificial joints belong to the field of medical consumables – high value consumables -C03 orthopedic materials – joint replacement implants.
02
Development driver
- Policy factor
Table 1. Policies and regulations related to artificial joints in recent years
|
TIME |
Policies |
Main Point |
| In December 2021 | The 14th Five-Year Plan for the Development of Medical Equipment Industry by the Healthcare Commission | Seven key areas are proposed, including diagnostic testing equipment, treatment equipment, monitoring and life support equipment, traditional Chinese medicine diagnosis and treatment equipment, maternal and child health equipment, active implantation interventional equipment, which basically covers the needs of the whole population from prevention, diagnosis, treatment to rehabilitation, care and all-round life-cycle medical service equipment. |
| In June 2021 | National Organization for Medical Consumables Joint Procurement Platform National Organization for Artificial Joint Concentrated Volume Procurement Announcement (No.1) | The aim is to further promote the reform of centralised quantity procurement of high-value medical consumables. The Announcement provides a comprehensive description of the product categories, procurement rules, and bidding rules for this centralized procurement. The products purchased in this centralized volume include the initial replacement of artificial total hip joints (divided into three product systems: ceramic, ceramic polyethylene, and alloy polyethylene), and the initial replacement of artificial total knee joints (divided into one product system for procurement). |
Data source: Official website of National Health Commission and Development and Reform Commission
- Social and economic factors
According to the Survey on the Prevalence of Primary Osteoarthritis in People Aged 40 and Over in China, the incidence rate of osteoarthritis increases with age. The prevalence of primary osteoarthritis in people aged 40-49, 50-59, 60-69, and 70 and over is 30.1%, 48.7%, 62.2%, and 62.0%, respectively. Osteoarthritis mainly occurs in the elderly. In recent years, the aging trend of the domestic population has intensified, and the market size of joint consumables is expected to grow rapidly.
In 2021, 538,000 sets of joint consumables were purchased in the first year of national collection, accounting for 90% of the total intended purchase volume. The average price drop of hip joint and knee joint reached 80% and 84% respectively, and the price of artificial joint products was greatly reduced, which will usher in a large outbreak of market demand.
03
Market Size
- Calculation logic
Determining the scope of application: Through the analysis of the application range and indications of artificial joint, the corresponding diseases and treatment methods are determined.
Determining the amount of surgery: The quantity of joint replacement operation is determined by the open data, and the data of future operation are deduced based on the population structure and population number.
Determining the product price: determine the use proportion and price of various joint consumables through the MDCLOUD of Joinchain and deduce the future product price trend through their price changes.
Measuring market size： Based on the operation volume and product price, the market size of artificial joint is estimated.
-
Data basis
(1) Online procurement data
The data range covers the prices of various artificial joints for online and centralized procurement from 2019 to 2021.
(2) Authoritative report：
It mainly includes the statistical data of the Chinese Hip Surgery Academic Conference and the statistical data of the Health Commission.
- Market size forecast
Based on the operation volume of artificial joint replacement from 2013 to 2018, the operation volume of hip joint replacement and knee joint replacement from 2019 to 2025 are calculated, and combined with the national centralised procurement market price, the market size of artificial joint in 2025 is estimated to be 6.955 billion yuan.
Figure 1. Market size of artificial joints （hip and knee） in China from 2019 to 2025E
Data Source：MDCLOUD
04
Market pattern
It is estimated that in 2021, the market share of hip joint is about 65%, and that of knee joint is about 35%. With the decrease of the price of artificial joint products and the increase of the aging population, the proportion of hip replacement will slightly increase.
Figure 2. Market share of China’s hip and knee joints in 2021
Data Source：MDCLOUD
China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com
Source：Joinchain Medical Device
Translated & edited ：Bradyknows
